Hoth Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
19.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.10
|
0.00
|
0.10
|
100.00%
|
|
2022-09-30
|
-2.39
|
-2.05
|
0.34
|
14.23%
|
|
2022-06-30
|
-2.37
|
-2.25
|
0.12
|
5.06%
|
|
2022-03-31
|
-3.50
|
-2.75
|
0.75
|
21.43%
|
|
2021-12-31
|
-3.12
|
-3.50
|
-0.38
|
-12.18%
|
|
2021-09-30
|
-3.37
|
-3.50
|
-0.13
|
-3.86%
|
|
2021-06-30
|
-4.25
|
-3.50
|
0.75
|
17.65%
|
|
2021-03-31
|
-2.50
|
-6.00
|
-3.50
|
-140.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.05
|
|
2021-12-31
|
-16.50
|
|
2020-12-31
|
-5.38
|
|
2019-12-31
|
-0.83
|
|
2018-12-31
|
-0.03
|